Browsing: Business

Fuel costs remained a major source of price pressure during the month. Petroleum product prices climbed 14.2% from a year earlier, though the increase slowed from July. Diesel prices jumped 19.6%, while gasoline prices rose 11.5%. Petroleum products added 0.54 percentage point to annual consumer price growth. South Korea relies heavily on imported energy, leaving domestic fuel costs sensitive to changes in global energy markets.

Korea’s August exports jump 68.7% to $98.25 billion as Asia’s fourth-largest economy extends its trade expansion streak for a 15th consecutive month. Semiconductor exports, the primary driver of national trade performance, soared 209% year-on-year to an all-time high of $46.65 billion. Energy and chemical sectors also contributed to monthly top-line gains. Petroleum product exports climbed 65.3% year-on-year to $6.84 billion, while petrochemical exports advanced 12.2% to $3.86 billion. Geographically, outbound deliveries to major trading partners demonstrated broad-based expansion.

The Ministry of Statistics and Programme Implementation put real gross domestic product at ₹81.36 lakh crore for the quarter. That compared with ₹75.46 lakh crore in the same period a year earlier. Nominal GDP reached ₹88.27 lakh crore, up 10.3% from ₹80 lakh crore. Real gross value added, another measure of economic activity, increased 8.2% to ₹73.82 lakh crore. Nominal GVA rose 11.5% to ₹80.53 lakh crore.

Japanese stocks came under sharp pressure Monday as the Nikkei 225 dropped nearly 2% in early trading. The benchmark fell 1.97% to 65,096.63 and later touched an intraday low of 64,832.10. Technology shares led much of the decline as investors reacted to higher bond yields and tighter interest rate expectations. The broader Topix also weakened early, falling 0.84% to 4,111.71. Japanese government bond yields rose at the same time, adding pressure to rate sensitive parts of the equity market.

The Ministry of Investment and Downstreaming and the Ministry of Youth and Sports in Indonesia have signed a memorandum of understanding to develop investment in the national sports sector. The agreement covers risk-based business licensing and investment development across sports-related activities, aiming to tap into the global sports industry worth about US$521 billion. The framework, part of Government Regulation No. 28 of 2025, streamlines licensing procedures for companies operating in sports and other related industries.

Brent futures rose 27 cents, or 0.3%, to $92.44 a barrel by 0330 GMT. U.S. West Texas Intermediate gained 37 cents, or 0.4%, to $85.38. The rebound followed Monday’s sharp pullback, which ended six consecutive sessions of gains across the two benchmark crude contracts.

Alibaba said it will direct 100% of the net proceeds toward its full-stack AI capabilities. The spending will include expansion and upgrades across its artificial intelligence infrastructure. The company has built an AI ecosystem spanning cloud computing, models, chips and applications. Its Qwen model family and Alibaba Cloud services form major parts of that technology platform.

South Korea has begun its first container ship trial through the Arctic to Europe. The 2,758-TEU PanStar Acro left Busan New Port at about 9 p.m. on August 22. The Ministry of Oceans and Fisheries confirmed the departure and published the voyage schedule. The ship will use the Northern Sea Route before calling at three European ports. The 45-day round trip is scheduled to end in Busan on October 5.

July marked the second consecutive monthly record for imports by value. Crude oil played a major role in the increase as Japan faced higher energy costs. Crude import volumes rose 5.5% from July 2025, ending three months of year-on-year declines. The value of those crude shipments jumped 87.8% over the same period. Japan remains heavily dependent on imported energy, making changes in oil prices and exchange rates important factors in its merchandise trade figures.

Healthcare stocks provided another source of support during Wednesday’s session as several pharmaceutical shares recorded large gains. Moderna shares surged 177%, while Merck advanced 12.6% after the companies announced positive results from a Phase 3 melanoma trial. The INTerpath-001 study tested personalized mRNA therapy intismeran autogene with Keytruda following surgical removal of high-risk melanoma. The combination met its primary endpoint for recurrence-free survival. It also met a key secondary endpoint measuring survival without distant cancer spread.